Product Description (via Amazon.com):
David Wolfson, a Jerusalem scientist, claims to have found the cure for cancer. He and his wife, Tamara, seek the help of Richard Lunz, a Tel Aviv attorney, to fight the powerful bureaucrats who want to appropriate David’s invention. Richard can’t resist the temptation to participate in what looks like the discovery of the century and it takes a first death to make him doubt that something in the project is not what it seems. And then other people die. Following clues that take him to Eastern Europe and to America, Richard finds more answers than he wished for. But he just can’t stop looking.
When Kfir Luzzatto asked me, in April, to read and review ExtraLife, Inc., I said yes, because it sounded like a really gripping read.
I was not disappointed, because in this novel Luzzatto gives us a medical and legal thriller that not only has great characters, but also looks at some crucial ethical issues: science vs. money is one of them, but another is the question of the line between professional ethics and scientific research.
Despite – or perhaps because of – the weighty themes, Luzzatto keeps the audience entertained. From the opening, where no names were used for over a page, and we, the reader, are a bit unsure what is happening, to the globe-spanning cat-and-mouse games; from the chilling knowledge that people are dying, to the book’s satisfying ending there is not one moment of dullness. The pacing allows us to become absorbed in the story with pauses to regroup, and at no point did I want to skip ahead or tune out.
To many, any book with “cancer” in the back-cover or flyleaf blurb may seem like it couldn’t possibly be entertaining, but ExtraLife, Inc. not only entertains, but provokes real thought.
Goes well with…
Chicken shawarma, Greek salad, and iced hibiscus tea.
Buy this book:
– At amazon.com using the link above.
– At smashwords.com
This review is based on a digital copy that was provided by the author. The published version may differ slightly in format and editing.